Your browser doesn't support javascript.
loading
Outcome of COVID-19 infection in 50 multiple myeloma patients treated with novel drugs: single-center experience.
Krejci, Marta; Pour, Ludek; Adam, Zdenek; Sandecka, Viera; Stork, Martin; Sevcikova, Sabina; Krejci, Martin; Knechtova, Zdenka; Kral, Zdenek.
Afiliação
  • Krejci M; Department of Internal Medicine, Hematology and Oncology, Faculty of Medicine, University Hospital Brno and Masaryk University, Jihlavska 20, Brno, 625 00, Czech Republic. krejci.marta@fnbrno.cz.
  • Pour L; Department of Internal Medicine, Hematology and Oncology, Faculty of Medicine, University Hospital Brno and Masaryk University, Jihlavska 20, Brno, 625 00, Czech Republic.
  • Adam Z; Department of Internal Medicine, Hematology and Oncology, Faculty of Medicine, University Hospital Brno and Masaryk University, Jihlavska 20, Brno, 625 00, Czech Republic.
  • Sandecka V; Department of Internal Medicine, Hematology and Oncology, Faculty of Medicine, University Hospital Brno and Masaryk University, Jihlavska 20, Brno, 625 00, Czech Republic.
  • Stork M; Department of Internal Medicine, Hematology and Oncology, Faculty of Medicine, University Hospital Brno and Masaryk University, Jihlavska 20, Brno, 625 00, Czech Republic.
  • Sevcikova S; Babak Myeloma Group, Department of Pathophysiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
  • Krejci M; Department of Internal Medicine, Hematology and Oncology, Faculty of Medicine, University Hospital Brno and Masaryk University, Jihlavska 20, Brno, 625 00, Czech Republic.
  • Knechtova Z; Department of Internal Medicine, Hematology and Oncology, Faculty of Medicine, University Hospital Brno and Masaryk University, Jihlavska 20, Brno, 625 00, Czech Republic.
  • Kral Z; Department of Internal Medicine, Hematology and Oncology, Faculty of Medicine, University Hospital Brno and Masaryk University, Jihlavska 20, Brno, 625 00, Czech Republic.
Ann Hematol ; 100(10): 2541-2546, 2021 Oct.
Article em En | MEDLINE | ID: mdl-34309714

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Bortezomib / Lenalidomida / COVID-19 / Anticorpos Monoclonais / Mieloma Múltiplo / Antineoplásicos Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: República Tcheca

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Bortezomib / Lenalidomida / COVID-19 / Anticorpos Monoclonais / Mieloma Múltiplo / Antineoplásicos Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: República Tcheca